Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · Real-Time Price · USD

2.790

+0.170 (6.49%)

At close: Jun 26, 2026, 4:00 PM EDT

2.840

+0.050 (1.79%)

After-hours: Jun 26, 2026, 7:47 PM EDT

Anixa Biosciences Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Revenue	-	-	-	0.21	-	0.51
Gross Profit	-	-	-	0.21	-	0.51
Selling, General & Admin	6.12	6.63	7.44	6.29	7.17	7.07
Research & Development	4.56	5.07	6.4	4.77	6.7	6.19
Other Operating Expenses	-	-	-	0.16	-	0.39
Total Operating Expenses	10.68	11.7	13.83	11.22	13.88	13.65
Operating Income	-10.68	-11.7	-13.83	-11.01	-13.88	-13.14
Interest Income	0.55	0.67	1.13	1.08	0.1	0
Other Non-Operating Income (Expense)	-	-	-	-	-	0.01
Total Non-Operating Income (Expense)	0.55	0.67	1.13	1.08	0.1	0.01
Pretax Income	-10.12	-11.03	-12.7	-9.93	-13.77	-13.13
Net Income	-10.12	-11.03	-12.7	-9.93	-13.77	-13.13
Minority Interest in Earnings	0.09	0.1	0.14	0.12	0.18	0.17
Net Income to Common	-10.03	-10.93	-12.55	-9.81	-13.6	-12.95
Shares Outstanding (Basic)	33	32	32	31	30	29
Shares Outstanding (Diluted)	33	32	32	31	30	29
Shares Change (YoY)	2.81%	1.74%	2.96%	1.99%	6.28%	28.57%
EPS (Basic)	-0.31	-0.34	-0.39	-0.32	-0.45	-0.45
EPS (Diluted)	-0.31	-0.34	-0.39	-0.32	-0.45	-0.45
Free Cash Flow	-7.12	-7.17	-7.34	-6.21	-6.49	-4.94
Free Cash Flow Per Share	-0.22	-0.22	-0.23	-0.20	-0.21	-0.17
Gross Margin	-	-	-	100.00%	-	100.00%
Operating Margin	-	-	-	-5243.33%	-	-2565.63%
Profit Margin	-	-	-	-4728.57%	-	-2564.06%
FCF Margin	-	-	-	-2956.67%	-	-964.45%
EBITDA	-10.64	-11.67	-13.79	-10.97	-13.83	-13.08
EBITDA Margin	-	-	-	-5221.43%	-	-2553.91%
EBIT	-10.68	-11.7	-13.83	-11.01	-13.88	-13.14
EBIT Margin	-	-	-	-5243.33%	-	-2565.63%

SEC Filings: 10-K · 10-Q